You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Mallinckrodt
Harvard Business School
Colorcon
McKinsey

Last Updated: January 26, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for SJG-136

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for SJG-136?

SJG-136 is an investigational drug.

There have been 4 clinical trials for SJG-136. The most recent clinical trial was a Phase 1 trial, which was initiated on July 1st 2010.

The most common disease conditions in clinical trials are Fallopian Tube Neoplasms, Leukemia, Myeloid, and Syndrome. The leading clinical trial sponsors are National Cancer Institute (NCI) and [disabled in preview].

Recent Clinical Trials for SJG-136
TitleSponsorPhase
SJG-136 in Treating Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer That Did Not Respond to Previous Treatment With Cisplatin or CarboplatinNational Cancer Institute (NCI)Phase 2
SJG-136 in Treating Patients With Relapsed or Refractory Acute Leukemia, Myelodysplastic Syndromes, Blastic Phase Chronic Myelogenous Leukemia, or Chronic Lymphocytic LeukemiaNational Cancer Institute (NCI)Phase 1
SJG-136 in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By SurgeryNational Cancer Institute (NCI)Phase 1

See all SJG-136 clinical trials

Clinical Trial Summary for SJG-136

Top disease conditions for SJG-136
Top clinical trial sponsors for SJG-136

See all SJG-136 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Mallinckrodt
Harvard Business School
Colorcon
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.